McKesson Corp. News

$50 Billion Opioid Settlement Bid Sparks States-Cities Fight

About $50 billion in settlement offers by drugmakers and distributors have sparked a fight between state attorneys general and thousands of local governments over how much the pharmaceutical industry should pay for its role in creating the U.S. opioid epidemic. …

J&J Makes $4 Billion Opioid Offer as Distributors Seek Deal

Johnson & Johnson has offered to pay $4 billion to settle all claims accusing the company of helping fuel the U.S. opioid epidemic, as part of a potentially larger deal involving drugmakers and distributors that could top $20 billion. J&J’s …

Opioid Fines Could Reach $150 Billion in Worst-Case Scenario

Monday’s $572 million judgment against Johnson & Johnson may mean one analyst’s “bear case scenario” of $150 billion in opioid damages just got one step closer. Patrick Trucchio, a Berenberg analyst, on Tuesday renewed his April projection for U.S. liabilities …

Opioid Distributors Propose $10 Billion to End State Claims

McKesson Corp., Cardinal Health Inc. and AmerisourceBergen Corp. have proposed paying $10 billion to settle claims they helped to fuel the U.S. opioid epidemic — the first sign of progress in resolving state lawsuits against the drug distributors, according to …

Opioid Judge Calls Proposed Settlement Group a ‘Novel Approach’

A judge backed a push by U.S. cities and counties suing opioid makers such as Purdue Pharma LP and Johnson & Johnson to negotiate a settlement as a group but put off until August a final decision on the request. …

Lawyers Pitch Plan to Include Entire U.S. in Opioid Settlement Talks

Lawyers representing county and municipal governments accusing drug manufacturers and distributors of fueling the U.S. opioid epidemic proposed a novel plan on Friday that would allow every community nationally to participate in negotiating billions of dollars in settlements. The proposal …

Vermont Sues 2 Prescription Opioid Distributors

BURLINGTON, Vt. — Vermont filed a lawsuit Tuesday against two pharmaceutical distributors, accusing them of selling ever-increasing amounts of prescription opioids in the state while failing to effectively monitor and control the sales and acknowledge the quantity of pills was …